Evidence map›Paper›PMID 36883164›Full record

ReviewArchives of Razi Institute2022

Role of Honey Bee Gut Microbiota in the Control of American Foulbrood and European Foulbrood Diseases.

M Moharrami, N Mojgani, M Bagheri, S Toutiaee

Open access · greenAbstract readReview
In one paragraph

Review in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Optimizing Conditions forPlants (Basel, Switzerland) · 2025
    Article
  3. Prevalence ofArchives of Razi Institute · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M MoharramiRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO) Karaj, 31976-19751, Iran.
N MojganiRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO) Karaj, 31976-19751, Iran.
M BagheriRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO) Karaj, 31976-19751, Iran.
S ToutiaeeRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO) Karaj, 31976-19751, Iran.
Islamic Azad University, Karaj · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

American foulbrood (AFB) and European foulbrood (EFB) are the two most important honey bee brood diseases which impose heavy economic losses to the apiculture industry worldwide by reducing bee population and honey production. Treatment with antibiotics has led to the emergence of antibiotic-resistant strains, calling for alternative safe treatment procedures that could control these diseases. Honey bee gut microbiota is known to affect the overall health of honey bees by enhancing their resistance to a number of diseases via modulation of the immune response and production of different antimicrobial metabolites. The majority of these gut resident bacteria are identified as probiotic bacteria and secure the health of these tiny insects. In the present review, we highlighted the significance of the honey bee gut microbial community and their probiotic potency for the prevention of AFB and EFB diseases in honey bees.

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBeekeepingBeesAnti-Bacterial AgentsAmerican foulbrood diseaseEuropean foulbrood diseasehoneybee microbiotaprobiotics

Identifiers

PMID36883164
PMCPMC9985789
OpenAlexW4323535535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.